Singapore, Singapore · Founded 2018 · Privately Held (backing)
Developer of an oncology-focused biotechnology platform designed to help in harnessing the power of digital and precision medicine. AUM Biosciences is based in Singapore, Singapore and was founded in 2018. Its last reported valuation was $98.7 million in Oct 2021. It has raised $29.7 million.
Last reported valuation
$98.7M
Oct 2026
Priced at
—
Total raised
$29.7M
Last round
—
Cap table — not yet on record
AUM Biosciences's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of AUM Biosciences with a free account
·Watch AUM Biosciences: the Monday email on marks, rounds and moves
